M. Kathleen Behrens - 08 Nov 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
08 Nov 2022
Net transactions value
+$1,028,550
Form type
4
Filing time
10 Nov 2022, 16:10:36 UTC
Previous filing
03 Oct 2022
Next filing
21 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Purchase $1,028,550 +60,000 +38% $17.14 218,200 08 Nov 2022 See footnote F1, F2
holding IGMS Common Stock 3,394 08 Nov 2022 Direct
holding IGMS Common Stock 29,807 08 Nov 2022 See footnote F3
holding IGMS Common Stock 29,806 08 Nov 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $16.94 to $17.25. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
F2 The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee.
F3 The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
F4 The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.